Tech Company Financing Transactions
Clinipace Funding Round
Private investors participated in a $13.3 million funding round for Clinipace. The round closed on 9/18/2012.
Transaction Overview
Company Name
Announced On
9/18/2012
Transaction Type
Debt
Amount
$13,285,811
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
3800 Paramount Pkwy. 100
Morrisville, NC 27560
USA
Morrisville, NC 27560
USA
Phone
Website
Email Address
Overview
As a digital CRO (dCRO), Clinipace pioneered an innovative service model to transform drug and medical device development by delivering technology-amplified services to improve performance, collaboration, and visibility across all stakeholders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jason Monteleone
Chief Financial Officer
Karen Turner
Chief Information Officer
Michael Townley
Chief Medical Officer
Sharon Moore
Chief Operating Officer
Susan Acker-Walsh
Vice President
Charlene Dark
Vice President
Brian Travers
VP - Bus. Development
John Cargill
VP - Bus. Development
Dawn Sauro
VP - General Counsel
Parker Honeycutt
VP - Human Resources
Judith Barnett
VP - Operations
Ian Fraser
VP - Operations
Cindy Venendaal
VP - Regulatory Affairs
Nikolas Burlew
VP - Regulatory Affairs
Marie Hanley
Browse more venture capital transactions:
Prev: 9/18/2012: BrightContext venture capital transaction
Next: 9/18/2012: Rivertop Renewables venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs